Target intelligence / Profile preview

Eustachian tube mucosa air-liquid interface (ET-ALI)

Target
ET-ALI
Molecular classification
Other
01

Overview

The Eustachian tube mucosa air-liquid interface (ALI) is a specialized biological model used to study the respiratory-type epithelium that lines the Eustachian tube (Kerschner et al., 2007). In this system, epithelial cells are cultured on a permeable membrane where the apical surface is exposed to air while the basolateral surface remains in contact with nutrient-rich media, mimicking the physiological environment of the human airway (Qin et al., 2020). This setup is crucial for the differentiation of the mucosa into a functional pseudostratified epithelium containing ciliated cells and mucus-secreting goblet cells. The ET-ALI model is primarily utilized in research to investigate the pathogenesis of otitis media and Eustachian tube dysfunction, particularly how the mucosal barrier responds to bacterial and viral infections (Jung et al., 2021). While it is not a molecular target for drug action, it serves as a vital tool for evaluating the efficacy and toxicity of intranasal or transtympanic pharmacological interventions, such as corticosteroids. By measuring parameters such as ciliary beat frequency and transepithelial electrical resistance, researchers can assess the impact of drugs on mucociliary clearance and barrier integrity. This model bridges the gap between traditional 2D cell cultures and in vivo animal models, providing a more accurate representation of human Eustachian tube physiology.

Other names
Eustachian tube epithelium air-liquid interfaceET mucosa ALI culturePharyngotympanic tube mucosa air-liquid interfaceHuman Eustachian tube epithelial cells (HETEC) ALI
02

Mechanism of action

Not applicable as this is a biological model/tissue system rather than a molecular target. It is used to evaluate drug effects on mucociliary clearance and barrier integrity.

03

Biological functions

Mucociliary clearanceEpithelial barrier functionInnate immune responsePressure regulationSecretory function
04

Disease associations

Otitis mediaEustachian tube dysfunctionInfectionInflammation
05

Safety considerations

Model variabilityLack of vascularization and systemic immune componentsIn vitro to in vivo translation challengesTechnical complexity of maintaining stable interface
06

Interacting drugs

Dexamethasone

4 more in the full profile.

07

Biomarkers

Transepithelial electrical resistance (TEER)Ciliary beat frequency (CBF)MUC5ACMUC5BBeta-tubulin IV

Beyond the preview

Go deeper on Eustachian tube mucosa air-liquid interface (ET-ALI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eustachian tube mucosa air-liquid interface (ET-ALI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call